Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Wiley, S.R. TI - Identification and characterization of a new member of the TNF family that induces apoptosis JO - Immunity PY - 1995/// VL - 3 SP - 673 EP - 682 M3 - 10.1016/1074-7613(95)90057-8 N1 - 10.1016/1074-7613(95)90057-8 UR - http://dx.doi.org/10.1016/1074-7613(95)90057-8 ER - TY - JOUR AU - Walczak, H. TI - Tumoricidal activity of tumor necrosis factor-related apoptosis- inducing ligand in vivo JO - Nature Med. PY - 1999/// VL - 5 SP - 157 EP - 163 M3 - 10.1038/5517 N1 - 10.1038/5517 UR - http://dx.doi.org/10.1038/5517 ER - TY - JOUR AU - Takeda, K. TI - Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells JO - Nature Med. PY - 2001/// VL - 7 SP - 94 EP - 100 M3 - 10.1038/83416 N1 - 10.1038/83416 UR - http://dx.doi.org/10.1038/83416 ER - TY - JOUR AU - Smyth, M.J. TI - Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis JO - J. Exp. Med. PY - 2001/// VL - 193 SP - 661 EP - 670 M3 - 10.1084/jem.193.6.661 N1 - 10.1084/jem.193.6.661 UR - http://dx.doi.org/10.1084/jem.193.6.661 ER - TY - JOUR AU - Kayagaki, N. TI - Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs JO - J. Exp. Med. PY - 1999/// VL - 189 SP - 1451 EP - 1460 M3 - 10.1084/jem.189.9.1451 N1 - 10.1084/jem.189.9.1451 UR - http://dx.doi.org/10.1084/jem.189.9.1451 ER - TY - JOUR AU - Appelbaum, F.R. TI - Haematopoietic cell transplantation as immunotherapy JO - Nature PY - 2001/// VL - 411 SP - 385 EP - 389 M3 - 10.1038/35077251 N1 - 10.1038/35077251 UR - http://dx.doi.org/10.1038/35077251 ER - TY - JOUR AU - Winter, H. AU - Hu, H.M. AU - Urba, W.J. AU - Fox, B.A. TI - Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L) JO - J. Immunol. PY - 1999/// VL - 163 SP - 4462 EP - 4472 ER - TY - JOUR AU - Braun, M.Y. AU - Lowin, B. AU - French, L. AU - Acha-Orbea, H. AU - Tschopp, J. TI - Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease JO - J. Exp. Med. PY - 1996/// VL - 183 SP - 657 EP - 661 M3 - 10.1084/jem.183.2.657 N1 - 10.1084/jem.183.2.657 UR - http://dx.doi.org/10.1084/jem.183.2.657 ER - TY - JOUR AU - Jeremias, I. AU - Herr, I. AU - Boehler, T. AU - Debatin, K.M. TI - TRAIL/Apo-2-ligand-induced apoptosis in human T cells JO - Eur. J. Immunol. PY - 1998/// VL - 28 SP - 143 EP - 152 M3 - 10.1002/1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3 N1 - 10.1002/1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3 UR - http://dx.doi.org/10.1002/1521-4141(199801)28:01<143::AID-IMMU143>3.0.CO;2-3 ER - TY - JOUR AU - Mariani, S.M. AU - Krammer, P.H. TI - Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells JO - Eur. J. Immunol. PY - 1998/// VL - 28 SP - 1492 EP - 148 M3 - 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.3.CO;2-O N1 - 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.3.CO;2-O UR - http://dx.doi.org/10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.3.CO;2-O ER - TY - JOUR AU - Schmaltz, C. TI - Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect JO - Blood PY - 2001/// VL - 97 SP - 2886 EP - 2895 M3 - 10.1182/blood.V97.9.2886 N1 - 10.1182/blood.V97.9.2886 UR - http://dx.doi.org/10.1182/blood.V97.9.2886 ER - TY - JOUR AU - Ashkenazi, A. TI - Safety and antitumor activity of recombinant soluble Apo2 ligand JO - J. Clin. Invest. PY - 1999/// VL - 104 SP - 155 EP - 162 ER - TY - JOUR AU - Ichikawa, K. TI - Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity JO - Nature Med. PY - 2001/// VL - 7 SP - 954 EP - 960 M3 - 10.1038/91000 N1 - 10.1038/91000 UR - http://dx.doi.org/10.1038/91000 ER - TY - JOUR AU - Jo, M. TI - Apoptosis induced in normal human hepatocytes by tumor necrosis factor[ndash]related apoptosis-inducing ligand JO - Nature Med. PY - 2000/// VL - 6 SP - 564 EP - 567 M3 - 10.1038/75045 N1 - 10.1038/75045 UR - http://dx.doi.org/10.1038/75045 ER - TY - JOUR AU - Lawrence, D. TI - Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions JO - Nature Med. PY - 2001/// VL - 7 SP - 383 EP - 385 M3 - 10.1038/86397 N1 - 10.1038/86397 UR - http://dx.doi.org/10.1038/86397 ER - TY - JOUR AU - Hattori, K. TI - Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies JO - Blood PY - 1998/// VL - 91 SP - 4051 EP - 4055 ER - TY - JOUR AU - Van den Brink, M.R. TI - Fas-deficient lpr mice are more susceptible to graft-versus-host disease JO - J. Immunol. PY - 2000/// VL - 164 SP - 469 EP - 480 ER - TY - JOUR AU - Bordignon, C. TI - Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms JO - Blood PY - 1989/// VL - 74 SP - 2237 EP - 2243 ER - TY - JOUR AU - Cretney, E. TI - Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice JO - J. Immunol. PY - 2002/// VL - 168 SP - 1356 EP - 1361 ER - TY - JOUR AU - Sedger, L.M. TI - Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice JO - Eur. J. Immunol. PY - 2002/// VL - 32 SP - 2246 EP - 2254 M3 - 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6 N1 - 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6 UR - http://dx.doi.org/10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6 ER - TY - JOUR AU - Matulonis, U. AU - Salgia, R. AU - Okuda, K. AU - Druker, B. AU - Griffin, J.D. TI - Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line JO - Exp. Hematol. PY - 1993/// VL - 21 SP - 1460 EP - 146 ER - TY - JOUR AU - Cooke, K.R. TI - An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin JO - Blood PY - 1996/// VL - 88 SP - 3230 EP - 3239 ER - TY - GEN AU - Crawford, J.M. TI - Graft-Versus-Host-Disease PY - 1997/// ER - TY - JOUR AU - Ferrara, J. AU - Guillen, F.J. AU - Sleckman, B. AU - Burakoff, S.J. AU - Murphy, G.F. TI - Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: Histologic analysis and correlation to clinical disease JO - J. Invest. Dermatol. PY - 1986/// VL - 86 SP - 371 EP - 375 M3 - 10.1111/1523-1747.ep12285612 N1 - 10.1111/1523-1747.ep12285612 UR - http://dx.doi.org/10.1111/1523-1747.ep12285612 ER -